Remotaid

Remotaid is a startup focusing on healthcare with the slogan "Protecting the Promise of Life with At-Home Fetal Monitoring." The company was founded in 2012 and has received a grant investment from MassChallenge in November 2014. Remotaid's innovative solution addresses the critical issue of prenatal death with its home-use fetal heart rate monitor. The USA sees 25,000 otherwise viable fetuses die annually during the third trimester out of 4 million childbirths. These deaths often occur without prior symptoms and can best be prevented through regular medical checkups. However, frequent hospital visits are not only financially burdensome but also time-consuming. Remotaid's portable fetal heart rate monitor offers a safe and convenient alternative for home use, employing a patented method that ensures zero harm to the fetus. This solution not only addresses a pressing healthcare need but also demonstrates potential for scalability and impact.